Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.22%17.74B | 18.77%17.35B | 26.55%4.93B | 0.74%4.32B | 24.17%4.35B | 28.35%3.75B | 10.35%14.61B | 6.96%3.9B | 29.52%4.28B | 18.09%3.51B |
| Cost of revenue | 5.26%15.73B | 20.16%14.95B | 22.74%3.99B | 6.75%3.81B | 27.93%3.83B | 26.35%3.31B | 8.14%12.44B | 9.13%3.25B | 20.71%3.57B | 15.10%3B |
| Gross profit | -16.69%2B | 10.82%2.4B | 45.76%939.88M | -29.39%502.8M | 2.12%521.44M | 45.65%440.88M | 25.01%2.17B | -2.75%644.81M | 104.32%712.09M | 39.35%510.63M |
| Operating expense | 16.03%1.96B | 14.78%1.69B | 13.05%429.8M | 15.08%455.75M | 9.76%404.47M | 22.00%402.9M | 6.89%1.47B | 6.39%380.17M | 17.89%396.03M | 11.56%368.49M |
| Operating profit | -94.48%39.28M | 2.41%712.08M | 92.75%510.09M | -85.11%47.05M | -17.71%116.96M | 237.91%37.98M | 95.21%695.3M | -13.44%264.64M | 2,411.44%316.07M | 293.41%142.14M |
| Net non-operating interest income (expenses) | -448.01%-31.56M | -201.99%-5.76M | -37.96%-3.34M | -223.28%-1.97M | -194.61%-492K | -96.51%45K | 75.74%-1.91M | -32.88%-2.42M | 63.91%-610K | 91.54%-167K |
| Non-operating interest income | 39.36%18.37M | 12.05%13.18M | 30.94%2.07M | 10.49%3.71M | 29.18%3.43M | -4.72%3.98M | 173.62%11.76M | 21.21%1.58M | 167.28%3.36M | 159.88%2.66M |
| Non-operating interest expense | 163.62%49.93M | 38.55%18.94M | 35.19%5.41M | 43.21%5.68M | 38.97%3.92M | 36.40%3.93M | 12.41%13.67M | 28.02%4M | 34.66%3.97M | -5.77%2.82M |
| Net investment income | -2.11%11.16M | 53.89%11.4M | -49.63%1.3M | 212.42%3.77M | 132.57%1.01M | 67.18%5.31M | -19.29%7.41M | 213.44%2.59M | -8.42%1.21M | -61.42%436K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 93.89%-5.91M | -5,662.89%-96.76M | -100M | 0 | -101.73%-1.68M | 0 | 74.41%-1.68M | |||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -31.01%31.67M | 749.38%45.91M | 802.91%34.3M | 801.75%10.04M | 872.22%1.58M | 0 | -110.23%-7.07M | -71.86%-4.88M | 87.35%-1.43M | -99.80%162K |
| Less:Other special charges | -51.59%-69.59M | -749.38%-45.91M | -802.91%-34.3M | -801.75%-10.04M | ---- | ---- | 110.23%7.07M | 71.86%4.88M | -87.35%1.43M | 99.80%-162K |
| Less:Write off | --37.92M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 124.34%4.8M | -447.13%-19.72M | -48.61%1.35M | 17.47%921K | -4,058.32%-23.08M | -35.46%1.09M | -12.03%5.68M | 186.76%2.62M | -81.33%784K | -33.98%583K |
| Income before tax | -92.36%49.44M | -7.25%647.15M | 68.99%443.69M | -80.97%59.8M | -30.68%99.23M | 299.19%44.43M | 31.64%697.73M | -13.29%262.55M | 21,793.51%314.34M | -35.57%143.15M |
| Income tax | -95.57%6.87M | -24.09%155.01M | 159.31%126.82M | -101.46%-1.56M | 7.39%11.95M | -51.60%17.81M | 120.05%204.2M | 123.11%48.91M | 218.49%107.37M | -14.76%11.13M |
| Net income | -91.35%42.57M | -0.28%492.14M | 48.32%316.87M | -70.35%61.37M | -33.89%87.28M | 145.04%26.62M | 12.88%493.53M | -23.94%213.64M | 688.61%206.97M | -36.87%132.02M |
| Net income continuous operations | -91.35%42.57M | -0.28%492.14M | 48.32%316.87M | -70.35%61.37M | -33.89%87.28M | 145.04%26.62M | 12.88%493.53M | -23.94%213.64M | 688.61%206.97M | -36.87%132.02M |
| Noncontrolling interests | -155.10%-1.98M | 1,805.69%3.6M | 5,292.96%3.69M | 69.04%-113K | -292.41%-310K | 10.20%335K | -104.22%-211K | -103.55%-71K | 34.12%-365K | -105.39%-79K |
| Net income attributable to the company | -90.88%44.55M | -1.05%488.54M | 46.54%313.18M | -70.35%61.48M | -33.70%87.59M | 144.25%26.28M | 14.23%493.74M | -23.37%213.71M | 699.07%207.33M | -36.39%132.1M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -90.88%44.55M | -1.05%488.54M | 46.54%313.18M | -70.35%61.48M | -33.70%87.59M | 144.25%26.28M | 14.23%493.74M | -23.37%213.71M | 699.07%207.33M | -36.39%132.1M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -90.99%0.289 | -90.11%3.207 | -159.19%-8.305 | -70.35%4.036 | -33.69%5.75 | 144.26%1.726 | 14.24%32.413 | -23.36%14.03 | 699.08%13.611 | -36.38%8.672 |
| Diluted earnings per share | -91.08%0.286 | -90.11%3.207 | -159.19%-8.305 | -70.35%4.036 | -33.69%5.75 | 144.26%1.726 | 14.24%32.413 | -23.36%14.03 | 699.05%13.6105 | -36.38%8.6718 |
| Dividend per share | 0.00%3 | 50.00%3 | 50.00%3 | 0 | 0 | 0 | 100.00%2 | 100.00%2 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |